Bacil Pharma has informed that it enclosed Compliance Certificate pursuant to Regulation 7(3) of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended 31st March, 2023 duly signed by both, the Compliance officer of the Company and the authorized representative of the Share Transfer Agent.
The above information is a part of company’s filings submitted to BSE.